Human Placenta-Derived Mesenchymal Stem Cells Ameliorate Diabetic Kidney Disease by Modulating the T Helper 17 Cell/ Regulatory T-Cell Balance through the Programmed Death 1 / Programmed Death-Ligand 1 Pathway
The authors investigated the therapeutic effects and immunomodulatory mechanisms of human placenta-derived mesenchymal stem cells in diabetic kidney disease.
[Biogerontology] Investigators explored the possibility of inducing aging-associated features in cell types of the central nervous system using hiPSC technology.
[Journal Of Neuroscience] The authors reported using human tumor specimens and primary spheroids from male and female patients that GlialCAM, was differentially expressed in subpopulations of glioblastoma cells.
[Molecular Psychiatry] Investigators showed that the PTENG132D allele disrupted early neuroectoderm formation during the first several days of organoid generation, and results in deficient electrophysiology.